Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial

Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial

Suthasinee Sinawat,1,2 Suthasinee Hemanak,1 Kwanchanok Chanthowong,1 Supat Sinawat,3 Yosanan Yospaiboon1,2 1Department of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; 2KKU Eye Center, Khon Kaen University, Khon Kaen, Thailand; 3Department of Physiology, Faculty of M...

Full description

Bibliographic Details
Main Authors: Sinawat S, Hemanak S, Chanthowong K, Yospaiboon Y
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:Clinical Ophthalmology
Subjects:
ziv-aflibercept
bevacizumab
central retinal vein occlusion
macular edema
Online Access:https://www.dovepress.com/intravitreal-ziv-aflibercept-versus-bevacizumab-for-nave-central-retin-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/intravitreal-ziv-aflibercept-versus-bevacizumab-for-nave-central-retin-peer-reviewed-fulltext-article-OPTH

Similar Items